companydata.dkcompanydata.dk

DLI - DANSK LÆGEMIDDEL INFORMATION A/S: Financial statements 2016

CVR: 17472682

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

DLI - DANSK LÆGEMIDDEL INFORMATION A/S (CVR 17472682) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 5,846,032 and a net result of DKK 6,794,758 compared with DKK 7,169,083 the year before. That is an increase of 243.9% compared with the year before. Equity in the 2016 report amounted to DKK 33,630,967. The solvency ratio was 24.4%. The company had 28 employees in the financial year.

Gross Profit
DKK 5,846,032
Profit/Loss
DKK 6,794,758
Equity
DKK 33,630,967
Total Assets
DKK 137,866,040
Employees
28

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-5.8M6.8M33.6M28
2015-1.7M7.2M27M28
2014100M18.4M7.2M39.8M42
201394.4M16.2M6.6M32.6M39

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like DLI - DANSK LÆGEMIDDEL INFORMATION A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2016

DLI - DANSK LÆGEMIDDEL INFORMATION A/S: The 2015 annual report is outMay 24, 2016

DLI - DANSK LÆGEMIDDEL INFORMATION A/S has published its annual report for 2015. Gross profit came to DKK 1,699,798, and the net result was DKK 7,169,083.

Mads Tang Dalsgaard joins the board of DLI - DANSK LÆGEMIDDEL INFORMATION A/SApr 6, 2016

As of April 6, 2016, Mads Tang Dalsgaard has joined the board of directors of DLI - DANSK LÆGEMIDDEL INFORMATION A/S.

Lone Henriette Andreasen leaves the board of DLI - DANSK LÆGEMIDDEL INFORMATION A/SApr 6, 2016

As of April 6, 2016, Lone Henriette Andreasen has left the board of directors of DLI - DANSK LÆGEMIDDEL INFORMATION A/S.

Thomas Gross Nødvig joins the board of DLI - DANSK LÆGEMIDDEL INFORMATION A/SMar 29, 2016

As of March 29, 2016, Thomas Gross Nødvig has joined the board of directors of DLI - DANSK LÆGEMIDDEL INFORMATION A/S.

Christophe Duret joins the board of DLI - DANSK LÆGEMIDDEL INFORMATION A/SMar 29, 2016

As of March 29, 2016, Christophe Duret has joined the board of directors of DLI - DANSK LÆGEMIDDEL INFORMATION A/S.

Carina Schaldemose Sørensen joins the board of DLI - DANSK LÆGEMIDDEL INFORMATION A/SMar 29, 2016

As of March 29, 2016, Carina Schaldemose Sørensen has joined the board of directors of DLI - DANSK LÆGEMIDDEL INFORMATION A/S.

Jan Ulrik Stevnsborg leaves the board of DLI - DANSK LÆGEMIDDEL INFORMATION A/SMar 29, 2016

As of March 29, 2016, Jan Ulrik Stevnsborg has left the board of directors of DLI - DANSK LÆGEMIDDEL INFORMATION A/S.

Signe Ryberg leaves the board of DLI - DANSK LÆGEMIDDEL INFORMATION A/SMar 29, 2016

As of March 29, 2016, Signe Ryberg has left the board of directors of DLI - DANSK LÆGEMIDDEL INFORMATION A/S.

Thomas Gross Nødvig leaves the board of DLI - DANSK LÆGEMIDDEL INFORMATION A/SMar 28, 2016

As of March 28, 2016, Thomas Gross Nødvig has left the board of directors of DLI - DANSK LÆGEMIDDEL INFORMATION A/S.

Christophe Duret leaves the board of DLI - DANSK LÆGEMIDDEL INFORMATION A/SMar 28, 2016

As of March 28, 2016, Christophe Duret has left the board of directors of DLI - DANSK LÆGEMIDDEL INFORMATION A/S.

About DLI - DANSK LÆGEMIDDEL INFORMATION A/S

DLI - DANSK LÆGEMIDDEL INFORMATION A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1993. The company is registered under the industry Udgivelse af bøger. The company was previously named A/S PSE 38 NR. 1647. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by LIF LÆGEMIDDELINDUSTRIFORENINGEN. The company has 79 employees (2026). In 2025, the company reported a gross profit of DKK 9,463,859 and a net result of DKK -22,064,794 compared with DKK 2,016,490 the year before. Equity in the 2025 report amounted to DKK 32,858,127.

Source: annual report 2025, Danish Business Authority